SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by ChromaDex Corporation on November 21, 2017, reporting events occurring on November 17, 2017. The filing addresses the closing of a private equity financing transaction previously announced on November 3, 2017.
Key Financial Metrics
The filing details a capital raise rather than operational financial performance. Key metrics related to the transaction include:
- Total Proceeds: $23.0 million
- Shares Issued: 5,609,755 shares of Common Stock
- Purchase Price: $4.10 per share
- Liquidity Impact: The transaction provides immediate cash inflow to the company.
The filing text does not provide clear values for revenue, profit, operating cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the increase in outstanding common stock and cash reserves resulting from the closing of the Financing. The shares were issued pursuant to a Securities Purchase Agreement and are not registered under the Securities Act of 1933, relying instead on exemptions under Section 4(a)(2) and Rule 506 of Regulation D.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure regarding the unregistered nature of the securities. The Purchasers represented that they are "accredited investors" and acquired the securities for investment purposes only, not for resale.
Investor Verification Checklist
- Verify the dilution impact of the 5,609,755 newly issued shares on existing shareholders.
- Confirm the use of proceeds from the $23.0 million financing in subsequent filings or press releases.
- Review the full Securities Purchase Agreement for any specific covenants or rights granted to the Purchasers.
- Check for any subsequent filings regarding the registration rights of the unregistered shares.